Multiple Endocrine Neoplasia 1 Gene Alterations in MEN1-Associated and Sporadic Lipomas

Authors:
  • AVAlexander O. Vortmeyer
    Alexander O. Vortmeyer
  • EPEvgenia Pak
    Evgenia Pak
  • RBRoland Böni
    Roland Böni
  • ZZZhengping Zhuang
    Zhengping Zhuang

Abstract
Multiple endocrine neoplasia 1 (MEN1) syndrome is characterized by the development of parathyroid adenomas, pituitary adenomas, and duodenal and/or pancreatic neuroendocrine tumors. The vast majority, and possibly all, of these tumors are characterized by two genetic hits—germline mutation of the MEN1 tumor suppressor gene combined with allelic deletion of the corresponding wild-type allele (1). Alterations of the MEN1 gene are not only found in MEN1-associated tumors but also, with decreasing frequency, in sporadic neuroendocrine tumors of the foregut (2,3), parathyroid tumors (4), and pituitary adenomas (5).